Europe Sepsis Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis – by Product (Instruments, Reagents and Assays, Blood Culture Media, and Software), Technology [Molecular Diagnostics (Polymerase Chain Reaction, Peptide Nucleic Acid-Fluorescent in Situ Hybridization, Syndromic Panel-Based Testing, and Microarrays), Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, and Microbiology], Method (Automated Diagnostics and Conventional Diagnostics), Test Type (Point-of-Care Tests and Laboratory Tests), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Others), and End User (Hospitals, Pathology and Reference Laboratories, and Others)

No. of Pages: 208
Report Code: BMIRE00025660
Category: Life Sciences
Europe Sepsis Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Sepsis Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Sepsis Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Sepsis Diagnostics Market Regional Analysis

6.2 Europe Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Sepsis Diagnostics Market Forecast Analysis

7. Europe Sepsis Diagnostics Market Analysis – by Product

7.1 Instruments
  • 7.1.1 Overview
  • 7.1.2 Instruments: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Reagents and Assays
  • 7.2.1 Overview
  • 7.2.2 Reagents and Assays: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Blood Culture Media
  • 7.3.1 Overview
  • 7.3.2 Blood Culture Media: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Software
  • 7.4.1 Overview
  • 7.4.2 Software: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Sepsis Diagnostics Market Analysis – by Technology

8.1 Molecular Diagnostics
  • 8.1.1 Overview
  • 8.1.2 Molecular Diagnostics : Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)

9. Europe Sepsis Diagnostics Market Analysis – by Method

9.1 Automated Diagnostics and Conventional Diagnostics
  • 9.1.1 Overview
  • 9.1.2 Automated Diagnostics and Conventional Diagnostics: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Sepsis Diagnostics Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Sepsis Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.2.1.1 Europe Sepsis Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 UK: Europe Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.1.2 UK: Europe Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.1.3 UK: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.1.4 UK: Europe Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.2 Germany: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.2.2 Germany: Europe Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.2.3 Germany: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.2.4 Germany: Europe Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.3 France: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 France: Europe Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.3.2 France: Europe Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.3.3 France: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.3.4 France: Europe Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.4 Russia: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.4.2 Russia: Europe Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.4.3 Russia: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.4.4 Russia: Europe Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.5 Italy: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.5.2 Italy: Europe Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.5.3 Italy: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.5.4 Italy: Europe Sepsis Diagnostics Market Breakdown, by Method
  • 10.2.1.6 Rest of Europe: Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Product
    • 10.2.1.6.2 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Technology
    • 10.2.1.6.3 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
    • 10.2.1.6.4 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Method

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Abbott
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Immunexpress Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 BD
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Danaher (Beckman Coulter)
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Luminex Corporation
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 bioMerieux SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 T2 Biosystems, Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Axis-Shield Diagnostics Ltd
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Sepsis Diagnostics Market

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • Immunexpress Inc.
  • BD
  • Danaher (Beckman Coulter)
  • Luminex Corporation
  • THERMO FISHER SCIENTIFIC INC.
  • bioMerieux SA
  • T2 Biosystems, Inc
  • Axis-Shield Diagnostics Ltd
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)